ArticlePharmaceuticals (Basel, Switzerland)2021

GANAB as a Novel Biomarker in Multiple Sclerosis: Correlation with Neuroinflammation and IFI35.

Roberto De Masi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.